<?xml version="1.0" encoding="UTF-8"?>
<p>Of the 69 patients, 46.4% (80% CI 38.7‐54.1) achieved CR (Table 
 <xref rid="ajh25238-tbl-0001" ref-type="table">1</xref>). For the primary analysis, CR (80% CI) was reported in 40.0% (31.9‐48.1) of patients aged ≥55 years and 88.9% (75.5‐100.0) in patients aged &lt;55 years; 37 (53.6% [80% CI 45.9‐61.3]) patients overall, 35 (54.7% [80% CI 46.7‐62.7]) with AML and 2 (40.0% [80% CI 11.9‐68.1]) with MDS achieved CR/CRi (Supporting Information 
 <xref rid="ajh25238-supitem-0001" ref-type="supplementary-material">Tables S3 and S4</xref>). The median (range) duration of CR was 94 (1‐480) days in all patients and 103 (1‐480) and 50 (1‐268) days in patients aged ≥55 years and &lt;55 years, respectively. The median (range) duration of CR, CRi, or MLFS across all patients was 53 (1‐480) days. The number of patients censored for CR duration was 16/24 (66.7%) and 5/8 (62.5%) in the groups aged ≥55 and &lt;55 years, respectively.
</p>
